Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05147675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v5
  2. Enrollment target: 20 to 92
    • Trial status: Recruiting to Active, Not Recruiting
    • Study description shortened, about 25 words
    • Study sites revised (2)
    v4
  3. Primary and study completion dates: Dec 2025 to Dec 1, 2027
    • Study sites: 1 to 2
    • Start date changed from estimate of Dec 2022 to Dec 1, 2022
    v3
  4. Start date: Dec 2021 to Dec 2022
    • Study description expanded, about 25 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.
Trial Details
NCT Number NCT05147675
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions
(from sponsor)		 Osteoarthritis, Spinal Arthritis
Related terms Osteoarthritis, Spondylarthritis
Enrollment 92 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov